![1]()
News
New reports help nail down myocarditis risk with COVID-19 vaccine
October 11, 2021
Myocarditis linked to the two mRNA SARS-CoV-2 vaccines is rare, usually mild and self-limited, and a lot less likely than the usually more severe cases seen in COVID-19.
News
Is AFib a stroke cause or innocent bystander? The debate continues
October 5, 2021
Many believe AFib is a risk marker for stroke, but new evidence suggests it may be a causal risk factor.
![1]()
News
Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs
September 27, 2021
SGLT2 inhibitor versus GLP-1 RA use was associated with a significantly lower rate of hospitalization for heart failure in people with diabetes.
News
Cardiogenic shock teams again tied to lower mortality
September 23, 2021
New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.
![1]()
News
Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
September 21, 2021
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it improved specificity for intermediate-high–risk PE.
![1]()
News
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
September 20, 2021
Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.
![1]()
News
Top 10 things to know about the AHA ACLS 2020 updates
September 17, 2021
A quick summary for hospitalists of the AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.
News
Poor lung function linked to risk for sudden cardiac death
September 16, 2021
Every standard deviation decrease in forced expiratory volume in 1 second (FEV1) was associated with a 23% increase in risk for sudden cardiac death.
News
COVID vaccine preprint study prompts Twitter outrage
September 16, 2021
The authors’ conclusions about rates of myocarditis after COVID vaccine in boys aged 12-17 years are attacked for supposedly stoking antivaccine sentiment.
![1]()
News
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF
September 14, 2021
The SGLT2 inhibitor dapagliflozin boosted KCCQ scores and 6-minute walk distance in HFpEF patients in a 324-patient randomized trial.
